Ignite Creation Date:
2025-12-24 @ 2:24 PM
Ignite Modification Date:
2026-01-01 @ 9:35 PM
Study NCT ID:
NCT06678659
Status:
RECRUITING
Last Update Posted:
2025-12-05
First Post:
2024-10-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Sponsor:
Recursion Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-21
Start Date Type:
ACTUAL
Primary Completion Date:
2028-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-10-29
First Submit QC Date:
None
Study First Post Date:
2024-11-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-05
Last Update Post Date Type:
ESTIMATED